S. El Kazzouli et al. / Tetrahedron Letters 46 (2005) 6163–6167
6167
11. Procedure for the synthesis of (E)-(7-[(4-methoxy-
benzenesulfonyl)-methyl-)-methylamino]-1H-4-indazolyl]-
acrylic acid methyl ester (5c): To a mixture of compound 4
(200 mg, 0.43 mmol), methyl acrylate (50 lL, 0.86 mmol)
and tetrabutylammonium iodide (324 mg, 0.86 mmol) in a
mixture of DMF/TEA (8 mL, 5/5, v/v) under argon was
added PdCl2(dppf) (30 mg, 0.043 mmol). The reaction
mixture was stirred overnight at 45 ꢁC and then the
solution was evaporated. Ethyl acetate (5 mL) was added
and the organic phase, washed with water and brine, was
dried over MgSO4. The solvent was removed in vacuo and
the residue was purified by column chromatography over
silica gel (eluted with a EtOAc/EP) to give 5c (143 mg,
79%). Mp 155–156 ꢁC. 1H NMR (acetone-d6, 250 MHz) d
3.23 (s, 3H, NCH3), 3.76 (s, 3H, OCH3), 3.88 (s, 3H,
OCH3), 4.32 (s, 3H, NCH3), 6.59 (d, 1H, J = 7.8 Hz), 6.80
(d, 1H, J = 16.0 Hz), 7.18 (d, 2H, J = 9.1Hz), 7.44 (d, 1H,
J = 7.8 Hz), 7.59 (d, 2H, J = 9.1Hz), 7.96 (d, 1H, J =
16.0 Hz), 8.50 (s, 1H). 13C NMR (acetone-d6, 62.89 MHz)
d 38.4, 39.4, 51.6, 55.7, 96.7, 114.5, 120.5, 121.5, 124.4,
125.4, 127.2, 127.6, 130.2, 131.2, 140.7, 136.8, 143.1, 166.4.
MS (+ESI): m/z = 416 [MH+].
14. Procedure for the synthesis of 4-methoxy-N-methyl-N-(4-
phenylethynyl-1-methyl-7-indazolyl)-benzenesulfonamide
(5e). To a solution of 4 (200 mg, 0.43 mmol), phenylacet-
ylene (70 lL, 0.63 mmol) and CuI (17 mg, 0.09 mmol) in a
mixture of DMF/TEA (8 mL, 5/5, v/v) under argon was
added Pd(PPh3)2Cl2 (30 mg, 0.043 mmol). The reaction
mixture was stirred at room temperature overnight and
then the solvent was evaporated. Ethyl acetate (5 mL) was
added and the organic phase, washed with water and
brine, was dried over MgSO4. The solvent removed in
vacuo and the residue was purified by column chroma-
tography over silica gel (eluted with a EtOAc/EP) to give
5e (132 mg, 71%). Mp 84–85 ꢁC. 1H NMR (acetone-d6,
250 MHz) d 3.32 (s, 3H, NCH3), 3.95 (s, 3H, OCH3), 4.39
(s, 3H, NCH3), 6.61(d, 1H, J = 7.5 Hz), 7.15–7.19 (m,
3H), 7.44–7.47 (m, 3H), 7.62–7.67 (m, 4H), 8.09 (s, 1H).
13C NMR (acetone-d6, 62.89 MHz) d 39.0, 40.1, 56.2, 94.4,
86.9, 115.1, 116.5, 124.9, 125.3, 128.0, 128.3, 128.7, 129.5,
129.8, 131.4, 132.5, 132.6, 137.9, 142.5. MS (+ESI):
m/z = 432 [MH+].
15. 4-Methoxy-N-methyl-N-(3-bromo-4-(4-methoxyphenyl)-1-
methyl-7-indazolyl)-benzenesulfonamide (13): Colorless
solid, yield 78%. Mp 178–179 ꢁC. 1H NMR (acetone-d6,
250 MHz) d 3.33 (s, 3H, NCH3), 3.87 (s, 3H, OCH3),
3.94 (s, 3H, OCH3), 4.39 (s, 3H, NCH3), 6.69 (d,
1H, J = 7.5 Hz), 6.86 (d, 1H, J = 7.5 Hz), 7.02 (d, 2H,
J = 8.7 Hz), 7.17 (d, 2H, J = 8.9 Hz), 7.36 (d, 2H,
J = 8.7 Hz), 7.67 (d, 2H, J = 8.9 Hz). 13C NMR (ace-
tone-d6, 62.89 MHz) d 39.4, 40.2, 55.6, 56.2, 113.9, 115.1,
117.4, 118.9, 123.6, 126.3, 126.4, 128.9, 129.1, 130.3, 131.4,
132.2, 137.3, 140.7, 164.5. MS (+ESI): m/z = 517.5 [MH+].
16. During the submission of this article, similar results were
published. Witulski, B.; Azcon, J. R.; Alayrac, C.;
Arnautu, A.; Collot, V.; Rault, S. Synthesis 2005, 771.
17. 4-Methoxy-N-[4-(4-methoxyphenyl)-1-methyl-3-naphtalen-
yl-7-indazolyl]-N-methylbenzenesulfonamide (14): Yellow
solid, yield 78%. Mp 109–110 ꢁC. 1H NMR (CDCl3,
250 MHz) d 3.35 (s, 3H, NCH3), 3.55 (s, 3H, OCH3), 3.89
(s, 3H, OCH3), 4.58 (s, 3H, NCH3), 6.14 (d, 2H, J =
7.8 Hz), 6.57 (d, 1H, J = 7.5 Hz), 6.71(d, 2H, J = 8.8 Hz),
6.82 (d, 1H, J = 7.5 Hz), 7.02 (d, 1H, J = 8.8 Hz), 7.22–
7.32 (m, 4H), 7.67–7.75 (m, 5H). 13C NMR (CDCl3,
62.89 MHz) d 39.1, 40.3, 55.2, 55.8, 112.2, 114.2, 121.1,
124.3, 124.7, 125.4, 125.8, 126.1, 127.6, 128.4, 128.7, 129.8,
130.5, 131.5, 132.7, 133.3, 137.8, 138.4, 143.5, 158.5, 163.5.
MS (+ESI): m/z = 564.0 [MH+].
12. Farina, V.; Kapadia, S.; Krishnan, B.; Wang, C.; Liebes-
kind, L. S. J. Org. Chem. 1994, 59, 5905.
13. Procedure for the synthesis of 4-methoxy-N-methyl-N-[4-
(furan-2-yl)-1-methyl-7-indazolyl]-benzenesulfonamide (5d):
To a solution of 4 (100 mg, 0.21 mmol), 2-(tributylstan-
nyl)furan (77 mg, 0.25 mmol) and triphenylarsin (153 mg,
0.5 mmol) in 1,4-dioxan (5 mL) under argon was added
Pd2(dba)3-CHCl3 (21mg, 0.021mmol). The reaction
mixture was heated at 80 ꢁC overnight and then the
solvent was evaporated. Ethyl acetate (5 mL) was added
and the organic phase, washed with water and brine, was
dried over MgSO4. The solvent was removed in vacuo
and the residue was purified by column chromatography
over silica gel (eluted with a EtOAc/EP) to give 5d
(70 mg, 82%). Mp 126–127 ꢁC. 1H NMR (acetone-d6,
250 MHz) d 3.32 (s, 3H, NCH3), 3.95 (s, 3H, OCH3),
4.40 (s, 3H, NCH3), 6.61(d, 1H, J = 7.8 Hz), 6.66 (dd,
1H, J = 1.5, 3.4 Hz), 7.11 (d, 1H, J = 3.4 Hz), 7.18 (d,
2H, J = 9.1Hz), 7.33 (d, 1H, J = 7.8 Hz), 7.65 (d, 2H,
J = 9.1Hz), 7.78 (d, 1H, J = 1.5 Hz), 8.44 (s, 1H). 13C
NMR (acetone-d6, 62.89 MHz) d 39.0, 40.2, 56.2, 109.2,
112.0, 115.1, 116.9, 122.8, 124.6, 125.5, 126.4, 129.1,
131.4, 133.0, 144.2, 138.6, 143.3, 153.3. MS (+ESI): m/z =
397 [MH+].